<DOC>
	<DOC>NCT02834377</DOC>
	<brief_summary>The purpose of this study is to evaluate the effectiveness of using the personal preoperatively assessed cardiac output in high-risk patients to guide perioperative administration of fluids and vasoactive drugs on predefined postoperative complications.</brief_summary>
	<brief_title>Personalized Hemodynamic Therapy in Patients Undergoing High-risk Surgery</brief_title>
	<detailed_description />
	<mesh_term>Postoperative Complications</mesh_term>
	<criteria>Patients ≥ 18 years undergoing a major abdominal procedure (including general, urological, gynaecological, and vascular) with an expected duration of surgery ≥ 90 min or presumed blood loss exceeding 1,000 mL (e.g., intrabdominal vascular surgery) and ≥ 1 of the following highrisk criteria: acute or chronic renal impairment (serum creatinine ≥ 1.3 mg/dL) predefined risk factors for cardiac or respiratory complications Immunodeficiency due to a therapy (e.g., immunosuppressants, chemotherapy, radiation, longterm or highdose steroids) Immunodeficiency due to specific diseases (e.g., leukaemia, lymphoma, AIDS) severe liver impairment (biopsy proven liver cirrhosis plus 1 of the following: portal hypertension or history of upper gastrointestinal bleeding due to portal hypertension or previous episodes of hepatic insufficiency/hepatic encephalopathy/hepatic coma Age ≥ 80 years Age &lt;18 years Pregnancy surgery for palliative treatment emergency procedure refusal of consent participation in another randomized controlled trial failure to meet inclusion criteria</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Cardiac Output</keyword>
	<keyword>Hemodynamics</keyword>
	<keyword>Perioperative Care</keyword>
</DOC>